SCHEDULE: Goldman Sachs Discloses Stake in Iris Acquisition Corp II
Schedule 13G Filing
Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 1.2% of Iris Acquisition Corp II's Class A ordinary shares.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G.
- This filing reports their beneficial ownership of 210,649 shares of Class A ordinary shares of Iris Acquisition Corp II.
- This ownership represents 1.2% of the class of securities.
- The filing is an amendment to a previous filing, with the event date requiring this amendment being June 30, 2026.
- Both entities are registered as brokers or dealers and investment advisers.
- The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as having a negative sentiment due to its nature as a routine disclosure of beneficial ownership, indicating no new positive developments or strategic shifts.
Positives
- Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, indicating standard business operations.
- The filing explicitly states that the securities were acquired and are held in the ordinary course of business, not for control purposes.
Negatives
- The filing is an amendment, suggesting a change or update to a previous ownership position, but the specific reason for the amendment is not detailed beyond the event date.
- The beneficial ownership is a relatively small percentage (1.2%), which may not indicate significant influence or strategic involvement.
Risks
- Potential for future changes in beneficial ownership by Goldman Sachs, which could impact market perception or trading activity.
- The nature of Iris Acquisition Corp II as a SPAC (implied by 'Acquisition Corp') carries inherent risks associated with de-SPAC transactions and target company integration.
Future Outlook
No specific future outlook or guidance is provided in this Schedule 13G filing, as it pertains to beneficial ownership disclosure.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
- "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and entities that acquire a significant, but not controlling, stake in a public company. This filing by Goldman Sachs is typical for a large financial institution managing various investment vehicles and client accounts.
Comparison to Industry Standards
- The 1.2% ownership stake is within the typical range for institutional investors filing Schedule 13G, which is generally for holdings between 5% and 20% where the investor does not intend to influence control.
- The classification of Goldman Sachs & Co. LLC as a broker-dealer and investment adviser aligns with industry standards for financial institutions engaged in such filings.
Stakeholder Impact
- Shareholders of Iris Acquisition Corp II: The filing provides transparency regarding a significant institutional investor's stake, which can influence market perception.
- Regulators (SEC): Ensures compliance with disclosure requirements for beneficial ownership.
- Competitors: Awareness of institutional holdings can inform competitive analysis.
Next Steps
- Iris Acquisition Corp II may continue its operations or pursue a business combination, subject to SPAC regulations.
- Goldman Sachs will continue to monitor its investment and may adjust its holdings based on market conditions and investment strategy.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Date of event which requires filing of this statement (Amendment No. 1). |
| 07/02/2026 | Expiration date of Power of Attorney for Goldman Sachs & Co. LLC. |
| 07/08/2026 | Expiration date of Power of Attorney for The Goldman Sachs Group, Inc. |
| 07/17/2026 | Date of certification and signature for the filing. |
Keywords
Schedule 13G, Beneficial Ownership, Iris Acquisition Corp II, Goldman Sachs, Class A ordinary shares, SPAC, Investment Adviser, Broker-Dealer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.